Characterisation of the antifungal effects of a plant-based compound, CIN-102, on the main septal filamentous fungi involved in human pathology. (June 2021)
- Record Type:
- Journal Article
- Title:
- Characterisation of the antifungal effects of a plant-based compound, CIN-102, on the main septal filamentous fungi involved in human pathology. (June 2021)
- Main Title:
- Characterisation of the antifungal effects of a plant-based compound, CIN-102, on the main septal filamentous fungi involved in human pathology
- Authors:
- D'Agostino, Maurine
Tesse, Nicolas
Lavergne, Rose Anne
Pape, Patrice Le
Bouchara, Jean Philippe
Frippiat, Jean Pol
Machouart, Marie
Debourgogne, Anne - Abstract:
- Highlights: CIN-102 has antifungal activity against the genera Aspergillus, Scedosporium and Fusarium . The various strains tested had no phenotypes of resistance against CIN-102. CIN-102 shows an effect on spore germination and fungal growth. The post-antifungal effect is important with CIN-102. ABSTRACT: Objectives: Today, the increase of invasive fungal infections and the emergence of resistant strains are observed in medical practice. New antifungals are expected, and the plant world offers a panel of potentially active molecules. CIN-102 is a mixture of seven different compounds of plant origin developed from the formulation of cinnamon essential oil. Methods: The in vitro activity of CIN-102 was characterised against Aspergillus spp., Fusarium spp. and Scedosporium spp. by studying the minimum inhibitory concentration (MIC), inoculum effect, germination inhibition, fungal growth, post-antifungal effect (PAFE) and synergy. Results: MICs determined for the three genera followed a unimodal distribution and their mean values ranged from 62–250 μg/mL. CIN-102 demonstrated an inoculum effect similar to voriconazole and amphotericin B, 100% inhibition of spore germination and a PAFE. Conclusion: CIN-102 has significant activity against filamentous fungi involved in human pathologies and should be further explored as a potential new treatment. Other studies regarding its mechanisms of action as well as animal investigations are awaited.
- Is Part Of:
- Journal of global antimicrobial resistance. Volume 25(2021)
- Journal:
- Journal of global antimicrobial resistance
- Issue:
- Volume 25(2021)
- Issue Display:
- Volume 25, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 25
- Issue:
- 2021
- Issue Sort Value:
- 2021-0025-2021-0000
- Page Start:
- 171
- Page End:
- 180
- Publication Date:
- 2021-06
- Subjects:
- Antifungal -- Fungi -- Fusarium -- Aspergillus -- Scedosporium
Drug resistance -- Periodicals
Drug resistance -- Periodicals
Drug resistance
Periodicals
616.9041 - Journal URLs:
- http://www.sciencedirect.com/science/journal/22137165 ↗
http://www.sciencedirect.com/ ↗
http://www.bibliothek.uni-regensburg.de/ezeit/?2710046 ↗
http://www.elsevier.com/locate/jgar ↗ - DOI:
- 10.1016/j.jgar.2021.03.017 ↗
- Languages:
- English
- ISSNs:
- 2213-7165
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17264.xml